Platelet reactivity inhibition following ticagrelor loading dose in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
Marc LaineVassili PanagidesCorinne FrereThomas CuissetCaroline GouarneBernard JouveFranck ThunyFranck PaganelliMarie-Christine AlessiJulien ManciniLaurent BonelloPublished in: Journal of thrombosis and haemostasis : JTH (2019)
In patients receiving a ticagrelor LD while undergoing PCI for ACS, PR using the VASP did not predict MACE or bleeding, but it was significantly associated with the occurrence of definite acute stent thrombosis.
Keyphrases
- acute coronary syndrome
- percutaneous coronary intervention
- patients undergoing
- antiplatelet therapy
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- liver failure
- coronary artery bypass grafting
- respiratory failure
- pulmonary embolism
- risk assessment
- atrial fibrillation
- drug induced
- coronary artery bypass
- aortic dissection
- heart failure
- coronary artery disease
- extracorporeal membrane oxygenation